Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Biomedical Engineer Presents Important Findings on the Responsiveness of Standing CT for Measurement of Knee Joint Space Narrowing at IOWAI 2018

Imaging is a critical tool in the diagnosis and management of osteoarthritis. The International Workshop on Osteoarthritis Imaging (IOWAI) was created to offer opportunities for osteoarthritis investigators to discuss issues and share findings related to imaging. This Workshop was first held in Ainring, Germany in 2017 and is now held annually at various locations in Europe and…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Imaging is a critical tool in the diagnosis and management of osteoarthritis. The International Workshop on Osteoarthritis Imaging (IOWAI) was created to offer opportunities for osteoarthritis investigators to discuss issues and share findings related to imaging. This Workshop was first held in Ainring, Germany in 2017 and is now held annually at various locations in Europe and North America. This year’s IOWAI will be held in Menton, France, on July 5-8. Thought leaders and influencers from academia, regulatory and funding agencies, and the medical equipment industry will be in attendance.

Kaitlin Rabe, Biomedical Research Assistant at the University of Kansas Medical Center, will be presenting a poster titled, “Responsiveness of Standing CT for Measurement of Knee Joint Space Narrowing Over 60 Months.” The study was sponsored by the National Institutes of Health, the University of Iowa, and the University of California, San Francisco.

In the workshop, Ms. Rabe will discuss the limitations of two-dimensional radiography when measuring joint space width (JSW). These 2D weight-bearing radiographs traditionally suffer from poor sensitivity when used to detect knee osteoarthritis and produce poor correlation with symptom progression.

Much of these issues can be attributed to the inherent limitations in the 2D radiography procedure, such as the dependence on X-ray beam alignment with the medial tibial plateau. In addition, the temporal and spatial heterogeneity of structural progression of knee OA limits the responsiveness of radiographic JSW to diagnose disease progression. MRI offers important advantages over 2D radiography, but is typically non-weight-bearing.

Standing CT (SCT) imaging holds the potential to overcome these limitations and enhance responsiveness in three-dimensional JSW measurements. This is because JSW is measured in a loaded position while avoiding bony overlap and error due to beam angle variations.

In her workshop, Ms. Rabe will provide preliminary data for the responsiveness of 3D JSW on SCT over 60 months using an early prototype of the CurveBeam LineUP system. The LineUP is a compact, ultra-low dose Cone Beam CT imaging system specifically designed for the orthopedic and podiatric specialties. Preliminary data calculated for 33 knees from 19 participants over 60 months support the hypothesis that 3D JSW exhibits a greater responsiveness than has been reported for radiography, similar to that for quantitative cartilage thickness measured on MRI over 12-months.

To get all the details on this important study, be sure to attend Ms. Rabe’s workshop at the IOWAI in Menton, France, July 5-8. For more details on accommodations and the all the workshops at this important conference, go to https://www.iwoai.org/.

Read more at curvebeam.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage. Holland & Knight said hospitals will be eligible for NTAP reimbursement for use of Aidoc’s CARE Body CT Multi-Triage beginning Oct. 1, 2026, with supplemental payments continuing for three years.

  • 01Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage.
  • 02Holland & Knight said CMS approved an NTAP designation for Aidoc’s CARE Body CT Multi-Triage, with hospitals eligible for NTAP reimbursement beginning Oct. 1, 2026, with supplemental payments continuing for three years.

Sep 23, 2026

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raised CAD $4.24 million in a pre-seed round, according to Fierce Healthcare. It plans to expand protocol-driven virtual specialty care across Canada and the U.S.

  • 01Blair Health raised CAD $4.24 million in pre-seed funding.
  • 02Qualified Health positions its AI platform around safety and governance, including clinician oversight, auditability and traceability, according to Fierce Healthcare.

Sep 23, 2026

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512